# Microdose Study of Melphalan, Bortezomib and Dexamethasone

> **NCT02109861** · EARLY_PHASE1 · UNKNOWN · sponsor: **Henrik Gregersen** · enrollment: 6 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Melphalan
- **DRUG:** Bortezomib
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02109861
- **Lead sponsor:** Henrik Gregersen
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2015-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02109861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02109861, "Microdose Study of Melphalan, Bortezomib and Dexamethasone". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02109861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*